— Know what they know.
Not Investment Advice
Also trades as: BIOG-B.ST (STO) · $vol 2M

BIOGY OTC

BioGaia AB (publ)
1W: +0.0% 1M: +0.0% 3M: +13.2% YTD: +13.2% 1Y: +10.7% 3Y: +58.4% 5Y: +30.2%
$12.45
+0.00 (+0.00%)
 
OTC · Healthcare · Drug Manufacturers - Specialty & Generic · Tech Score Neutral · Power 56 · $1.3B mcap · 84M float · 0.0000% daily turnover · Short 90% of daily vol
Smart Money Score
No convergence signal
Key Statistics
Market Cap$1.3B
52W Range9.64-12.45
Volume270
Avg Volume1
Beta0.32
Dividend$0.42
Analyst Ratings
No analyst coverage
Company Info
CEOTheresa Agnew
Employees242
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
IPO Date2021-01-08
Kungsbroplan 3
Stockholm, AB 112 27
SE
46 8 55 52 93 00
About BioGaia AB (publ)

BioGaia AB (publ) is a global enterprise dedicated to the development, marketing, and sale of probiotic products, all backed by documented health benefits. The company organizes its activities into three primary divisions: Pediatrics, Adult Health, and 'Other'. Within the Pediatric segment, BioGaia provides items such as liquid drops, oral rehydration solutions, and gut health tablets, alongside supplying probiotic cultures for integration into infant formula. The Adult Health segment offers both digestive health tablets and oral hygiene lozenges, as well as providing cultures that are incorporated into dairy products by its licensees. The 'Other' segment focuses on delivering packaging solutions. BioGaia's product portfolio addresses a wide array of health conditions, including infantile colic and digestive problems in children, acute and antibiotic-associated diarrhea, gingivitis, periodontal disease, general wellness, Helicobacter pylori infections (the bacterium causing gastric ulcers), and low bone density. All of the company's products are sold under the BioGaia brand. Founded in 1990, BioGaia AB (publ) is headquartered in Stockholm, Sweden.

Recent Insider Trades

No insider trades found

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms